{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:33:25Z","timestamp":1780097605127,"version":"3.54.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00330-020-07026-x","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T11:03:52Z","timestamp":1596020632000},"page":"458-467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy?"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-4465","authenticated-orcid":false,"given":"Elisabeth","family":"O\u2019Dwyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh F.","family":"Halpenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"issue":"4","key":"7026_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271\u2013289. https:\/\/doi.org\/10.3322\/caac.21349","journal-title":"CA Cancer J Clin"},{"issue":"10125","key":"7026_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 391(10125):1023\u20131075. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3","journal-title":"Lancet."},{"issue":"6","key":"7026_CR3","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374\u20131403. https:\/\/doi.org\/10.1016\/j.ejca.2012.12.027","journal-title":"Eur J Cancer"},{"key":"7026_CR4","unstructured":"Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA FJJ. New malignancies among cancer survivors - SEER Cancer Registries, 1973-2000 - SEER Publications. Bethesda, MD. NIH Publ. No. 05-5302"},{"issue":"19","key":"7026_CR5","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/cncr.30164","volume":"122","author":"NM Donin","year":"2016","unstructured":"Donin NM, Filson CP, Drakaki A et al (2016) Risk of second primary malignancies among cancer survivors in the United States, 1992-2008. Cancer. 122(19):3075\u20133086. https:\/\/doi.org\/10.1002\/cncr.30164","journal-title":"Cancer."},{"issue":"6","key":"7026_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.rmed.2014.02.015","volume":"108","author":"N Reinmuth","year":"2014","unstructured":"Reinmuth N, Stumpf P, Stumpf A et al (2014) Characteristics of lung cancer after a previous malignancy. Respir Med 108(6):910\u2013917. https:\/\/doi.org\/10.1016\/j.rmed.2014.02.015","journal-title":"Respir Med"},{"key":"7026_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1245\/s10434-008-0296-1","volume":"16","author":"S Quadrelli","year":"2009","unstructured":"Quadrelli S, Lyons G, Colt H, Chimondeguy DSC (2009) Lung cancer as a second primary malignancy: increasing prevalence and its influence on survival. Ann Surg Oncol 16:1033\u20131010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7026_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ejcts.2007.06.024","volume":"32","author":"H-S Hofmann","year":"2007","unstructured":"Hofmann H-S, Neef H, Schmidt P (2007) Primary lung cancer and extrapulmonary malignancy. Eur J Cardiothorac Surg 32(4):653\u2013658. https:\/\/doi.org\/10.1016\/j.ejcts.2007.06.024","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"7026_CR9","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/hed.22006","volume":"34","author":"MT Milano","year":"2012","unstructured":"Milano MT, Peterson CR, Zhang H, Singh DP, Chen Y (2012) Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors. Head Neck 34(12):1782\u20131788. https:\/\/doi.org\/10.1002\/hed.22006","journal-title":"Head Neck"},{"issue":"1","key":"7026_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1464-410X.2009.09081.x","volume":"106","author":"J Del Rey","year":"2009","unstructured":"Del Rey J, Placer J, Vallmanya F et al (2009) Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial? BJU Int 106(1):49\u201352. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.09081.x","journal-title":"BJU Int"},{"issue":"5","key":"7026_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Adams AM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395\u2013409. https:\/\/doi.org\/10.1056\/NEJMoa1102873","journal-title":"N Engl J Med"},{"issue":"6","key":"7026_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","volume":"382","author":"HJ De Koning","year":"2020","unstructured":"De Koning HJ, Van Der Aalst CM, De Jong PA et al (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382(6):503\u2013513. https:\/\/doi.org\/10.1056\/NEJMoa1911793","journal-title":"N Engl J Med"},{"issue":"4","key":"7026_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.6004\/jnccn.2018.0020","volume":"16","author":"DE Wood","year":"2018","unstructured":"Wood DE, Kazerooni EA, Baum SL et al (2018) Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16(4):412\u2013441. https:\/\/doi.org\/10.6004\/jnccn.2018.0020","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"7026_CR14","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s00330-015-3697-0","volume":"25","author":"H-U Kauczor","year":"2015","unstructured":"Kauczor H-U, Bonomo L, Gaga M et al (2015) ESR\/ERS white paper on lung cancer screening. Eur Radiol 25(9):2519\u20132531. https:\/\/doi.org\/10.1007\/s00330-015-3697-0","journal-title":"Eur Radiol"},{"issue":"8","key":"7026_CR15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJMoa1211776","volume":"368","author":"MC Tammem\u00e4gi","year":"2013","unstructured":"Tammem\u00e4gi MC, Katki HA, Hocking WG et al (2013) Selection criteria for lung-cancer screening. N Engl J Med 368(8):728\u2013736. https:\/\/doi.org\/10.1056\/NEJMoa1211776","journal-title":"N Engl J Med"},{"issue":"5","key":"7026_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10552-019-01161-7","volume":"30","author":"NM Donin","year":"2019","unstructured":"Donin NM, Kwan L, Lenis AT, Drakaki A, Chamie K (2019) Second primary lung cancer in United States cancer survivors, 1992\u20132008. Cancer Causes Control 30(5):465\u2013475. https:\/\/doi.org\/10.1007\/s10552-019-01161-7","journal-title":"Cancer Causes Control"},{"issue":"9","key":"7026_CR17","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.jtho.2016.05.006","volume":"11","author":"DF Halpenny","year":"2016","unstructured":"Halpenny DF, Cunningham JD, Long NM, Sosa RE, Ginsberg MS (2016) Patients with a previous history of malignancy undergoing lung cancer screening: clinical characteristics and radiologic findings. J Thorac Oncol 11(9):1447\u20131452. https:\/\/doi.org\/10.1016\/j.jtho.2016.05.006","journal-title":"J Thorac Oncol"},{"key":"7026_CR18","unstructured":"LungRADS v 1.0| ACR. https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/Lung-Rads. Accessed February 19, 2020"},{"key":"7026_CR19","doi-asserted-by":"publisher","unstructured":"National Lung Screening Trial Research Team, Church TR, Black WC et al (2013) Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368(21):1980\u20131991. https:\/\/doi.org\/10.1056\/NEJMoa1209120","DOI":"10.1056\/NEJMoa1209120"},{"issue":"12","key":"7026_CR20","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S1470-2045(14)70387-0","volume":"15","author":"N Horeweg","year":"2014","unstructured":"Horeweg N, Scholten ET, de Jong PA et al (2014) Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15(12):1342\u20131350. https:\/\/doi.org\/10.1016\/S1470-2045(14)70387-0","journal-title":"Lancet Oncol"},{"issue":"3","key":"7026_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/CEJ.0b013e328351e1b6","volume":"21","author":"U Pastorino","year":"2012","unstructured":"Pastorino U, Rossi M, Rosato V et al (2012) Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21(3):308\u2013315. https:\/\/doi.org\/10.1097\/CEJ.0b013e328351e1b6","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"7026_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S1470-2045(15)00621-X","volume":"17","author":"EF Patz","year":"2016","unstructured":"Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR (2016) Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 17(5):590\u2013599. https:\/\/doi.org\/10.1016\/S1470-2045(15)00621-X","journal-title":"Lancet Oncol"},{"issue":"7","key":"7026_CR23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","volume":"25","author":"SM Bluethmann","year":"2016","unstructured":"Bluethmann SM, Mariotto AB, Rowland JH (2016) Anticipating the \u201cSilver Tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 25(7):1029\u20131036. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0133","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"7026_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","volume":"15","author":"R De Angelis","year":"2014","unstructured":"De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5\u2014a population-based study. Lancet Oncol 15(1):23\u201334. https:\/\/doi.org\/10.1016\/S1470-2045(13)70546-1","journal-title":"Lancet Oncol"},{"key":"7026_CR25","unstructured":"NCCN Colorectal Screening Guidelines v2019.2. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colorectal_screening.pdf Accessed April 4, 2020"},{"key":"7026_CR26","unstructured":"American Cancer Society Recommendations for Prostate Cancer Early Detection. | ACR https:\/\/www.cancer.org\/cancer\/prostate-cancer\/detection-diagnosis-staging\/acs-recommendations.html. Accessed April 4, 2020"},{"issue":"1","key":"7026_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5320\/wjr.v6.i1.1","volume":"6","author":"CP Erkmen","year":"2016","unstructured":"Erkmen CP, Kaiser LR, Ehret AL (2016) Lung cancer screening: should we be excluding people with previous malignancy? World J Respirol 6(1):1. https:\/\/doi.org\/10.5320\/wjr.v6.i1.1","journal-title":"World J Respirol"},{"key":"7026_CR28","unstructured":"2014 surgeon general\u2019s report: the health consequences of smoking\u201450 years of progress | CDC. https:\/\/www.cdc.gov\/tobacco\/data_statistics\/sgr\/50th-anniversary\/index.htm#report. Accessed August 20, 2019"},{"issue":"1","key":"7026_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jtcvs.2012.09.030","volume":"145","author":"F Lou","year":"2013","unstructured":"Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB (2013) Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg 145(1):75\u201382. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.09.030","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5 Pt 1","key":"7026_CR30","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/s0022-5347(17)32435-7","volume":"152","author":"E Salminen","year":"1994","unstructured":"Salminen E, Pukkala E, Teppo L (1994) Bladder cancer and the risk of smoking-related cancers during followup. J Urol 152(5 Pt 1):1420\u20131423. https:\/\/doi.org\/10.1016\/s0022-5347(17)32435-7","journal-title":"J Urol"},{"key":"7026_CR31","doi-asserted-by":"publisher","unstructured":"Westeel V, Barlesi F, Foucher P et al (2017) 1273OResults of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC). Ann Oncol 28(suppl_5). https:\/\/doi.org\/10.1093\/annonc\/mdx378.012","DOI":"10.1093\/annonc\/mdx378.012"},{"issue":"11","key":"7026_CR32","doi-asserted-by":"publisher","first-page":"S1788","DOI":"10.1016\/j.jtho.2017.09.422","volume":"12","author":"V Westeel","year":"2017","unstructured":"Westeel V, Barlesi F, Foucher P et al (2017) OA 16.03 recurrences and 2nd primary cancers in the IFCT-0302 trial assessing a CT-scan-based follow-up after lung cancer surgery. J Thorac Oncol 12(11):S1788\u2013S1789. https:\/\/doi.org\/10.1016\/j.jtho.2017.09.422","journal-title":"J Thorac Oncol"},{"issue":"10","key":"7026_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/0003489415582259","volume":"124","author":"NA Pagedar","year":"2015","unstructured":"Pagedar NA, Jayawardena A, Charlton ME, Hoffman HT (2015) Second primary lung cancer after head and neck cancer. Ann Otol Rhinol Laryngol 124(10):765\u2013769. https:\/\/doi.org\/10.1177\/0003489415582259","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"24","key":"7026_CR34","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1002\/cncr.26257","volume":"117","author":"MT Milano","year":"2011","unstructured":"Milano MT, Li H, Constine LS, Travis LB (2011) Survival after second primary lung cancer. Cancer. 117(24):5538\u20135547. https:\/\/doi.org\/10.1002\/cncr.26257","journal-title":"Cancer."},{"issue":"8","key":"7026_CR35","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/JTO.0000000000000213","volume":"9","author":"MT Milano","year":"2014","unstructured":"Milano MT, Strawderman RL, Venigalla S, Ng K, Travis LB (2014) Non\u2013small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women. J Thorac Oncol 9(8):1081\u20131090. https:\/\/doi.org\/10.1097\/JTO.0000000000000213","journal-title":"J Thorac Oncol"},{"issue":"4","key":"7026_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/J.JACR.2018.07.011","volume":"16","author":"M Kaminetzky","year":"2019","unstructured":"Kaminetzky M, Milch HS, Shmukler A et al (2019) Effectiveness of Lung-RADS in reducing false-positive results in a diverse, underserved, urban lung cancer screening cohort. J Am Coll Radiol 16(4):419\u2013426. https:\/\/doi.org\/10.1016\/J.JACR.2018.07.011","journal-title":"J Am Coll Radiol"},{"key":"7026_CR37","unstructured":"Calculator: solitary pulmonary nodule malignancy risk in adults (Brock University cancer prediction equation) - UpToDate. https:\/\/www.uptodate.com\/contents\/calculator-solitary-pulmonary-nodule-malignancy-risk-in-adults-brock-university-cancer-prediction-equation. Accessed September 13, 2019"},{"issue":"1","key":"7026_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1148\/radiol.2018181050","volume":"291","author":"CS White","year":"2019","unstructured":"White CS, Dharaiya E, Dalal S, Chen R, Haramati LB (2019) Vancouver risk calculator compared with ACR Lung-RADS in predicting malignancy: analysis of the National Lung Screening Trial. Radiology. 291(1):205\u2013211. https:\/\/doi.org\/10.1148\/radiol.2018181050","journal-title":"Radiology."},{"issue":"2","key":"7026_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1148\/radiol.2019190905","volume":"293","author":"MM Hammer","year":"2019","unstructured":"Hammer MM, Palazzo LL, Kong CY, Hunsaker AR (2019) Cancer risk in subsolid nodules in the National Lung Screening Trial. Radiology. 293(2):441\u2013448. https:\/\/doi.org\/10.1148\/radiol.2019190905","journal-title":"Radiology."},{"issue":"8","key":"7026_CR40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/thoraxjnl-2017-210770","volume":"73","author":"MA Heuvelmans","year":"2018","unstructured":"Heuvelmans MA, Walter JE, Vliegenthart R et al (2018) Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening. Thorax. 73(8):779\u2013781. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210770","journal-title":"Thorax."}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07026-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-07026-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07026-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:19:19Z","timestamp":1627514359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-07026-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["7026"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-07026-x","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Michelle S. Ginsberg, MD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects or cohorts have been previously reported in <i>J Thorac Oncol<\/i>. 2016 Sep;11 (9):1447\u201352.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}